Jubilant Ingrevia Q1 FY27: net profit up 41% to ₹106 crore, revenue up 25%
Jubilant Ingrevia (BSE: JUBLINGREA) said it has published its Q1 FY27 results (consolidated), reporting revenue of ₹1,300 crore (+25.3% year on year), net profit of ₹106 crore (+40.9%), earnings per share of ₹6.7. The company is valued at about ₹10,399 crore.
What happened
Jubilant Ingrevia (BSE: JUBLINGREA) informed the stock exchanges on 27 October 2026 at 02:10 PM that it has published its Q1 FY27 results (consolidated), reporting revenue of ₹1,300 crore (+25.3% year on year), net profit of ₹106 crore (+40.9%), earnings per share of ₹6.7.
From the filing: "A copy of aforesaid Financial Results and 2."
Company snapshot
Jubilant Ingrevia is a small-cap company in the Chemicals sector, with a market value of about ₹10,399 crore.
The stock last traded at ₹652.9, against a 52-week range of ₹537.3–₹795 (17.9% below the high).
Before this filing the shares had moved −2.5% over the month and −17.0% over three months. Average daily turnover over the last 20 sessions was about ₹16.12 crore.
Promoters held 45.22% at the end of Q1 FY27; 9.30% of promoter shares were pledged. Foreign institutions owned 6.49% and domestic institutions 24.98%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 1,038 | 75.1 | 4.75 |
| Q2 FY26 | 1,121 | 69.5 | 4.4 |
| Q3 FY26 | 1,051 | 46.9 | 2.97 |
| Q4 FY26 | 1,179 | 86.4 | 5.47 |
| Q1 FY27 | 1,300 | 105.8 | 6.7 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock fell 4.7% on average the next trading day and was down 8.2% on average after five days (2 filings with price data).
Across 196 similar disclosures by other Chemicals companies, shares moved −0.7% on average the next day and −0.6% over five days; 39% of them rose the next day.
Market-wide, 9,766 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 22 Jul 2026 | Standalone And Consolidated Financial Results Of The Company For The… | −2.5% | −3.4% |
| 26 May 2026 | Audited Financial Results For The Quarter And Year Ended March 31,… | −7.0% | −12.9% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 27 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.